An international research team, led by Professor Wenbo Bu of Fudan University and Distinguished Professor Dayong Jin of the University of Technology Sydney, have discovered an innovative method to effectively treat cancer by reactivating suppressed metabolic pathways in cancer cells.
Amgen and AstraZeneca ponder label expansion for Tezspire in COPD
Tezspire is a thymic stromal lymphopoietin (TSLP) inhibiting monoclonal antibody co-developed by Amgen and AstraZeneca with the former in charge of manufacturing and the latter
May 20, 2024